Neuberger Berman Group LLC Acquires 41,074 Shares of STERIS plc $STE

Neuberger Berman Group LLC increased its holdings in shares of STERIS plc (NYSE:STE) by 211.5% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 60,490 shares of the medical equipment provider’s stock after buying an additional 41,074 shares during the quarter. Neuberger Berman Group LLC owned 0.06% of STERIS worth $14,968,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. Norges Bank bought a new position in STERIS in the second quarter valued at about $289,132,000. Orbis Allan Gray Ltd grew its holdings in shares of STERIS by 36.0% during the 2nd quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock valued at $504,486,000 after purchasing an additional 556,088 shares during the last quarter. Thrivent Financial for Lutherans increased its position in STERIS by 246.4% during the 3rd quarter. Thrivent Financial for Lutherans now owns 553,834 shares of the medical equipment provider’s stock worth $137,041,000 after purchasing an additional 393,970 shares in the last quarter. Invesco Ltd. lifted its stake in STERIS by 32.2% in the 2nd quarter. Invesco Ltd. now owns 1,220,699 shares of the medical equipment provider’s stock valued at $293,236,000 after purchasing an additional 297,076 shares during the last quarter. Finally, Assenagon Asset Management S.A. boosted its position in STERIS by 305.9% in the third quarter. Assenagon Asset Management S.A. now owns 330,907 shares of the medical equipment provider’s stock valued at $81,880,000 after buying an additional 249,386 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

Insider Activity at STERIS

In other news, Director Cynthia L. Feldmann sold 3,098 shares of the stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $237.21, for a total value of $734,876.58. Following the completion of the sale, the director owned 705 shares of the company’s stock, valued at approximately $167,233.05. This represents a 81.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a report on Saturday. Six analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $275.20.

STERIS Stock Down 3.4%

NYSE:STE opened at $230.49 on Friday. STERIS plc has a one year low of $204.90 and a one year high of $269.44. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.48 and a quick ratio of 1.75. The company has a market cap of $22.60 billion, a PE ratio of 32.15 and a beta of 1.05. The firm’s 50 day simple moving average is $254.37 and its 200 day simple moving average is $251.54.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. STERIS’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.32 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. On average, research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Tuesday, February 17th will be given a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Tuesday, February 17th. STERIS’s payout ratio is 35.15%.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.